Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Prevalence of chronic kidney disease (CKD) in people with diagnosed diabetes is known to be high, but little is known about the prevalence of CKD in those with undiagnosed diabetes or prediabetes. We aimed to estimate and compare the community prevalence of CKD among people with diagnosed diabetes, undiagnosed diabetes, prediabetes, or no diabetes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The 1999 through 2006 National Health and Nutrition Examination Survey is a representative survey of the civilian, noninstitutionalized US population. Participants who were aged > or =20 years; responded to the diabetes questionnaire; and had fasting plasma glucose (FPG), serum creatinine, and urinary albumin-creatinine ratio measurements were included (N = 8188). Diabetes status was defined as follows: Diagnosed diabetes, self-reported provider diagnosis (n = 826); undiagnosed diabetes, FPG > or =126 mg/dl without self-reported diagnosis (n = 299); prediabetes, FPG > or =100 and <126 mg/dl (n = 2272); and no diabetes, FPG <100 mg/dl (n = 4791). Prevalence of CKD was defined by estimated GFR 15 to 59 ml/min per 1.73 m(2) or albumin-creatinine ratio > or =30 mg/g; adjustment was performed with multivariable logistic regression. RESULTS: Fully 39.6% of people with diagnosed and 41.7% with undiagnosed diabetes had CKD; 17.7% with prediabetes and 10.6% without diabetes had CKD. Age-, gender-, and race/ethnicity-adjusted prevalence of CKD was 32.9, 24.2, 17.1, and 11.8%, for diagnosed, undiagnosed, pre-, and no diabetes, respectively. Among those with CKD, 39.1% had undiagnosed or prediabetes. CONCLUSIONS: CKD prevalence is high among people with undiagnosed diabetes and prediabetes. These individuals might benefit from interventions aimed at preventing development and/or progression of both CKD and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, evidence of a cross-sectional association between prediabetes and eGFR, a late marker of CKD, is mixed, including both studies with positive54 and null findings.55,57”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“The NHANES 1999–2006 showed increasing frequency of albuminuria in tandem with the glycaemia range when classified from normoglycaemia through IFG, undiagnosed diabetes and diagnosed diabetes for both microalbuminuria, which may also relate to hypertension and is therefore an imprecise marker of diabetes-related early nephropathy (6%, 10%, 29% and 29%, respectively) and macroalbuminuria (0.6%, 1.1”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
In the citing paper
“There is evidence to link prediabetes to increased risk of early forms of nephropathy and chronic kidney disease (CKD), defined based on methods such as urinary albumin excretion rate (AER) and estimated glomerular filtration rate (eGFR).51–55”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Self-citationDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725 · cited 9×
“The unadjusted CKD prevalence using the MDRD Study equation (7) was 39.6 and 41.7% in those with diagnosed and undiagnosed diabetes, respectively (Figure 1A).”
MethodInfluentialSelf-citationBasevi, V., Di Mario, S., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,055
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., Williams, D. E., Gregg, E. W., Bainbridge, K. E., Saydah, S. H., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1296 · Cited by 1,154
Self-citationChronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., & Hostetter, T. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070539 · Cited by 842
Self-citationKramer, H. J. (2003) · JAMA · doi:10.1001/jama.289.24.3273 · Cited by 618 · cited 1×
“We defined CKD as either reduced kidney function or elevated albuminuria, because reduced kidney function may occur even in the absence of albuminuria in those with type 2 diabetes (5,6).”
BackgroundImprovements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002
Saaddine, J. B., Cadwell, B., Gregg, E. W., Engelgau, M. M., Vinicor, F., Imperatore, G., & Narayan, K. M. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-7-200604040-00005 · Cited by 571
Research works printed but not linked: 3
- US Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009 [Google Scholar]
- Centers for Disease Control and Prevention: National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2007, Atlanta, US Department of Health and Human Services, Centers for Disease Control and Prevention, 2008. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf Accessed February 1, 2009 [Google Scholar]
- Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290: 2159–2167, 2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
Cited by
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958
The Global Epidemiology of Diabetes and Kidney Disease
Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.10.011 · Cited by 686
Self-citationPre-Diabetes, Metabolic Syndrome, and Cardiovascular Risk
Grundy, S. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.080 · Cited by 627
Global estimates of undiagnosed diabetes in adults
Beagley, J., Guariguata, L., Weil, C., & Motala, A. A. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.001 · Cited by 586
“[5] Plantinga LC, Crews DC, Coresh J, Miller 3rd ER, Saran R, Yee J, et al.”
BackgroundKDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
Lentine, K. L., Kasiske, B. L., Levey, A. S., Adams, P. L., Alberú, J., Bakr, M. A., Gallon, L., Garvey, C. A., Guleria, S., Li, P. K.-T., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001769 · Cited by 582
“Type 2 diabetes is a leading cause of CKD worldwide and accounts for approximately 50% of acquired, adult-onset ESKD.(261,262) Patients with diabetes mellitus are commonly excluded from living kidney donation.”
Prediabetes diagnosis and treatment: A review
Bansal, N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.296 · Cited by 579
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
“7% of patients with prediabetes have KD (527).”
BackgroundDiagnosis and Management of Prediabetes: A Review
Echouffo-Tcheugui, J. B., Perreault, L., Ji, L., & Dagogo-Jack, S. (2023) · JAMA · doi:10.1001/jama.2023.4063 · Cited by 473
Prediabetes and what it means: the epidemiological evidence
Echouffo-Tcheugui, J. B., & Selvin, E. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102644 · Cited by 406
“Data from the 1999– 2006 NHANES showed that approximately 18% of US adults with prediabetes have some form of chronic kidney disease (85).”
BackgroundEpidemiology of Diabetic Kidney Disease
Reutens, A. T. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.10.001 · Cited by 326
“5%.(83) Overall prevalence of CKD (defined by low eGFR or albuminuria) in prediabetes was 16.”
BackgroundDiabesity: an overview of a rising epidemic
Farag, Y. M. K., & Gaballa, M. R. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq576 · Cited by 320
“7% in patients with diagnosed and undiagnosed diabetes, respectively [27].”
BackgroundUpdate of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2013
IDF Diabetes Atlas Group (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.037 · Cited by 296
Prediabetes and Lifestyle Modification: Time to Prevent a Preventable Disease
Tuso, P. (2014) · The Permanente Journal · doi:10.7812/tpp/14-002 · Cited by 252
Bailey, R. A., Wang, Y., Zhu, V., & Rupnow, M. F. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-415 · Cited by 247
“[19] using NHANES 1999–2006 and a similar staging of CKD reported a slightly lower prevalence of CKD than this study.”
MethodLópez‐Candales, A., Burgos, P. M. H., Hernández-Suárez, D. F., & Harris, D. A. (2017) · PubMed · Cited by 252
Wu, B., Bell, K., Stanford, A., Kern, D. M., Tunceli, O., Vupputuri, S., Kalsekar, I., & Willey, V. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000154 · Cited by 216
Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease
Tonelli, M., Karumanchi, S. A., & Thadhani, R. (2016) · Circulation · doi:10.1161/circulationaha.115.018713 · Cited by 213
Ali, M. K., Bullard, K. M., Saydah, S., Imperatore, G., & Gregg, E. W. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30027-5 · Cited by 208
“complications.(22, 23) Furthermore, per capita health expenditures for adults with prediabetes are higher than expenditures in the general public and grow when people progress to diabetes.”
BackgroundClinical predictive factors in diabetic kidney disease progression
Radcliffe, N. J., Seah, J., Clarke, M., MacIsaac, R. J., Jerums, G., & Ekinci, E. I. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12533 · Cited by 208
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Landstra, C. P., & de Koning, E. J. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.649525 · Cited by 206
Preventing CKD in Developed Countries
Luyckx, V. A., Cherney, D. Z. I., & Bello, A. K. (2020) · Kidney International Reports · doi:10.1016/j.ekir.2019.12.003 · Cited by 176
“6% without diabetes.(59) Similarly, 28% of subjects with diagnosed hypertension were found to have CKD.”
BackgroundPrevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study
Mainous, A. G., Tanner, R. J., Baker, R., Zayas, C. E., & Harle, C. A. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005002 · Cited by 187
Prediabetes and associated disorders
Buysschaert, M., Medina, J. L., Bergman, M., Shah, A., & Lonier, J. (2014) · Endocrine · doi:10.1007/s12020-014-0436-2 · Cited by 184
Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes
Teumer, A., Tin, A., Sorice, R., Gorski, M., Yeo, N. C., Chu, A. Y., Li, M., Li, Y., Mijatovic, V., Ko, Y.-A., et al. (2016) · Diabetes · doi:10.2337/db15-1313 · Cited by 160
“adult population (5), and the presence of CKD is an important contributor to the excess mortality in diabetes (6).”
BackgroundSelf-citationBuysschaert, M., & Bergman, M. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.11.002 · Cited by 177
Echouffo‐Tcheugui, J. B., Narayan, K. M., Weisman, D., Golden, S. H., & Jaar, B. G. (2016) · Diabetic Medicine · doi:10.1111/dme.13113 · Cited by 150
Adipokines as a link between obesity and chronic kidney disease
Briffa, J. F., McAinch, A. J., Poronnik, P., & Hryciw, D. H. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00263.2013 · Cited by 153
Chronic Kidney Disease Awareness Among Individuals with Clinical Markers of Kidney Dysfunction
Tuot, D. S., Plantinga, L. C., Hsu, C.-Y., Jordan, R., Burrows, N. R., Hedgeman, E., Yee, J., Saran, R., & Powe, N. R. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00730111 · Cited by 154
“As in other research endeavors (27,28), lack of longitudinal data may have led to inclusion of individuals with acute kidney injury and not CKD.”
BackgroundSelf-citationCefalu, W. T., Buse, J. B., Tuomilehto, J., Fleming, G. A., Ferrannini, E., Gerstein, H. C., Bennett, P. H., Ramachandran, A., Raz, I., Rosenstock, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0873 · Cited by 142
Alfego, D., Ennis, J. L., Gillespie, B. S., Lewis, M. J., Montgomery, E., Ferrè, S., Vassalotti, J. A., & Letovsky, S. I. (2021) · Diabetes Care · doi:10.2337/dc21-0723 · Cited by 151
Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study
Rodriguez-Poncelas, A., Garre-Olmo, J., Franch-Nadal, J., Diez-Espino, J., Mundet-Tuduri, X., Barrot-De la Puente, J., Coll-de Tuero, G., & RedGDPS Study Group (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-46 · Cited by 135
“[22] showed that 32.”
Impaired fasting glucose is associated with renal hyperfiltration in the general population
Melsom, T., Mathisen, U. D., Ingebretsen, O. C., Jenssen, T. G., Njølstad, I., Solbu, M. D., Toft, I., & Eriksen, B. O. (2011) · Diabetes Care · doi:10.2337/dc11-0235 · Cited by 134
Daniele, G., Winnier, D., Mari, A., Bruder, J., Fourcaudot, M., Pengou, Z., Tripathy, D., Jenkinson, C., & Folli, F. (2015) · Diabetes Care · doi:10.2337/dc14-2989 · Cited by 125
Altered N‐glycosylation profiles as potential biomarkers and drug targets in diabetes
Rudman, N., Gornik, O., & Lauc, G. (2019) · FEBS Letters · doi:10.1002/1873-3468.13495 · Cited by 140
Bakris, G. L. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0713 · Cited by 145
“7%).(6) The presence of CKD also adds considerably to the cost of diabetes management.”
BackgroundKristian, R. E. T. T., & Gottwald‐Hostalek, U. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1601455 · Cited by 137
Clinical Manifestation and Natural History of Diabetic Nephropathy
Ritz, E., Zeng, X.-X., & Rychlík, I. (2011) · Contributions to Nephrology · doi:10.1159/000324939 · Cited by 114
Melsom, T., Schei, J., Stefansson, V. T. N., Solbu, M. D., Jenssen, T. G., Mathisen, U. D., Wilsgaard, T., & Eriksen, B. O. (2016) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.10.025 · Cited by 102
Chronic kidney disease and diabetes
Pyram, R., Kansara, A., Banerji, M. A., & Loney‐Hutchinson, L. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.11.009 · Cited by 119
Obesity and Chronic Kidney Disease
Kopple, J. D. (2010) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.05.008 · Cited by 115
Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study
Kowall, B., Rathmann, W., Stang, A., Bongaerts, B. W. C., Kuß, O., Herder, C., Roden, M., Quante, A. S., Holle, R., Huth, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171152 · Cited by 109
Pinchevsky, Y., Butkow, N., Raal, F. J., Chirwa, T. F., & Rothberg, A. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s226010 · Cited by 109
Edwards, C., & Cusi, K. J. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2016.06.007 · Cited by 121
Wen, J., Wang, A., Liu, G., Wang, M., Zuo, Y., Li, W., Zhai, Q., Mu, Y., Gaisano, H. Y., He, Y., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01401-9 · Cited by 94
“Also, prediabetes is related to increased risk of developing similar T2DM complications occurring in the eye [2], kindney [3] and cardiocerebral vascular system [4].”
BackgroundEffective CKD Care in European Countries: Challenges and Opportunities for Health Policy
Bello, A. K., Levin, A., Manns, B., Feehally, J., Drüeke, T. B., Faruque, L. I., Hemmelgarn, B. R., Kernahan, C., Mann, J. F. E., Klarenbach, S. W., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.07.033 · Cited by 98
Asmelash, D., & Asmelash, Y. (2019) · Journal of Diabetes Research · doi:10.1155/2019/4134937 · Cited by 92
“7% of adults with newly diagnosed diabetes have developed chronic kidney disease [9].”
BackgroundHsueh, W., McLellan, K., Wyne, K., & Villagomez, E. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s39564 · Cited by 91
“6% without diabetes or prediabetes.(13) In the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) study, the prevalence of diabetic polyneuropathy was approximately increased twofold in those individuals with IFG and IGT as compared with the normal subjects.”
Triglyceride glucose-body mass index in identifying high-risk groups of pre-diabetes
Jiang, C., Yang, R., Kuang, M., Meng, Y., Zhong, M., & Zou, Y. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01594-7 · Cited by 99
Screening for Type 2 Diabetes and Dysglycemia
Echouffo-Tcheugui, J. B., Ali, M. K., Griffin, S. J., & Narayan, K. M. V. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxq020 · Cited by 93
Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania
Janmohamed, M. N., Kalluvya, S. E., Müeller, A., Kabangila, R., Smart, L. R., Downs, J. A., & Peck, R. N. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-183 · Cited by 83
“4-29% [16-23].”
Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease
Piccoli, G. B., Grassi, G., Cabiddu, G., Nazha, M., Roggero, S., Capizzi, I., Pascale, A. D., Priola, A. M., Vico, C. D., Maxia, S., et al. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.87 · Cited by 90
“Akbari A, Clase CM, Acott P, Battistella M, Bello A, Feltmate P, Grill A, Karsanji M, Komenda P, Madore F, et al. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.”
BackgroundInfluentialThe economic burden of progressive chronic kidney disease among patients with type 2 diabetes
Vupputuri, S. X., Kimes, T. M., Calloway, M. O., Christian, J. B., Bruhn, D. F., Martin, A. A., & Nichols, G. A. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.09.014 · Cited by 91
Evidence for current diagnostic criteria of diabetes mellitus
Kumar, R., Nandhini, L. P., Kamalanathan, S., Sahoo, J., & Vivekanadan, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i17.396 · Cited by 95
Davies, M., Chatterjee, S., & Khunti, K. (2016) · Clinical Pharmacology: Advances and Applications · doi:10.2147/cpaa.s82008 · Cited by 75
“Conclusion Improved blood glucose control through pharmacological intervention can reduce the incidence and progression of CKD.(8,13,14) CKD is a common complication of T2D and should inform the choice of initial and subsequent drug therapy based on individualized glycemic targets.”
Damtie, S., Biadgo, B., Baynes, H. W., Ambachew, S., Melak, T., Asmelash, D., & Abebe, M. (2018) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v28i6.3 · Cited by 95
“This result is consistent with other studies’ outputs in various areas (18, 22, 2426).”
ResultMechanisms of Vascular Complications in Prediabetes
Milman, S., & Crandall, J. P. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2010.11.004 · Cited by 73
“73 m(2)) was 17% in those with IFG compared with 12% in those with NGT.(95) There seems to be a threshold effect for”
InfluentialHandelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Beckman, J. A., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., et al. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108101 · Cited by 64
Obesity and Type 2 Diabetes in Sub-Sahara Africa
Mbanya, J. C., Assah, F. K., Saji, J., & Atanga, E. N. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0501-5 · Cited by 77
DeJesus, R. S., Breitkopf, C. R., Rutten, L. J., Jacobson, D. J., Wilson, P. M., & Sauver, J. S. (2017) · Population Health Management · doi:10.1089/pop.2016.0067 · Cited by 61
Estimating Risks of De Novo Kidney Diseases After Living Kidney Donation
Steiner, R. W., Ix, J. H., Rifkin, D. E., & Gert, B. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12625 · Cited by 61
“Type II diabetes causes almost half of all acquired, adultonset ESRD (10) and causes even more chronic kidney disease, about 25% of which may go unrecognized as diabetic (11).”
BackgroundCytokine profiling of young overweight and obese female African American adults with prediabetes
Lucas, R., Parikh, S. J., Sridhar, S., Guo, D.-H., Bhagatwala, J., Dong, Y., Caldwell, R. B., Mellor, A. L., Caldwell, W., Zhu, H., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.05.025 · Cited by 69
Huang, J., Huth, C., Covic, M., Troll, M., Adam, J., Zukunft, S., Prehn, C., Wang, L., Nano, J., Scheerer, M. F., et al. (2020) · Diabetes · doi:10.2337/db20-0586 · Cited by 60
Health risks and interventions in prediabetes: A review
Mahat, R. K., Singh, N., Arora, M., & Rathore, V. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.041 · Cited by 52
Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
Kim, J. H., Kim, D. J., Jang, H. C., & Choi, S. H. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.6.571 · Cited by 63
Okwechime, I. O., Roberson, S. L., & Odoi, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145781 · Cited by 65
“Pre-diabetes increases the risk of type 2 diabetes that consequently predisposes individuals to heart disease, stroke, nerve damage, kidney failure, and eye problems [5, 7].”
BackgroundNah, E., Cho, S., Kim, S., & Cho, H.-I. (2016) · Annals of Laboratory Medicine · doi:10.3343/alm.2017.37.1.28 · Cited by 59
“Prediabetes is clinically significant because of its association with the progression of macrovascular and microvascular pathology, which results in high risks of retinopathy [1], cardiovascular diseases [2-4], and chronic renal diseases [5].”
BackgroundGroop, P. ‐., Del Prato, S., Taskinen, M. ‐., Owens, D. R., Gong, Y., Crowe, S., Patel, S., von Eynatten, M., & Woerle, H. ‐. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12281 · Cited by 51
“A similar proportion has been reported in subjects with undiagnosed diabetes [6].”
BackgroundPresentation, pathology and prognosis of renal disease in type 2 diabetes
Tan, J. S., Zwi, L. J., Collins, J. F., Marshall, M. R., & Cundy, T. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000412 · Cited by 51
Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007–2012
Bullard, K. M., Ali, M. K., Imperatore, G., Geiss, L. S., Saydah, S., Albu, J., Cowie, C. C., Sohler, N., Albright, A. L., & Gregg, E. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125249 · Cited by 51
“7% of people with prediabetes have chronic kidney disease [29].”
BackgroundZambrowicz, B., Lapuerta, P., Strumph, P., Banks, P. L., Wilson, A., Ogbaa, I., Sands, A., & Powell, D. R. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.10.026 · Cited by 51
“By 2006, 17% to 18% of US patients known to have type 2 diabetes, nearly 3 million people, were in this GFR range, as were an estimated 10% of US patients with prediabetes, defined as a fasting blood glucose level 4100 and o126 mg/dL.(5) Patients with type 2 diabetes are at increased risk for cardiovascular (CV) disea…”
BackgroundVasnawala, H., Prasannakumar, M., Rajput, R., Seshadri, K., Talwalkar, P., Agarwal, P., Gokulnath, G., Kotak, B., Raza, A., & Teli, C. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.157857 · Cited by 50
“9% in those with diagnosed diabetes.[15] In this survey, an eGFR of 15–59 ml/min/1.”
BackgroundCefalu, W. T. (2016) · Diabetes Care · doi:10.2337/dc16-1143 · Cited by 48
Gabriel, R., Boukichou-Abdelkader, N., Acosta, T., Gilis‐Januszewska, A., Gómez‐Huelgas, R., Makrilakis, K., Kamenov, Z. A., Paulweber, B., Satman, İ., Djordjević, P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231196 · Cited by 52
Lin, L., Peng, K., Du, R., Huang, X., Lu, J., Xu, Y., Xu, M., Chen, Y., Bi, Y., & Wang, W. (2017) · Obesity · doi:10.1002/oby.21768 · Cited by 47
“73 m(2) or albuminuria (UACR 30 mg/g) (27).”
Shevalye, H., Lupachyk, S., Watcho, P., Stavniichuk, R., Khazim, K., Abboud, H. E., & Obrosova, I. G. (2012) · Endocrinology · doi:10.1210/en.2011-1997 · Cited by 52
Microalbuminuria in HIV Disease
Hadigan, C. M., Edwards, E. W., Rosenberg, A., Purdy, J., Fleischman, E., Howard, L., Mican, J. M., Sampath, K., Oyalowo, A. O., Johnson, A., et al. (2013) · American Journal of Nephrology · doi:10.1159/000350384 · Cited by 45
Xing, F., Neeland, I. J., Gore, M. O., Ayers, C. R., Paixao, A. R. M., Turer, A. T., Berry, J. D., Khera, A., de Lemos, J. A., & McGuire, D. K. (2013) · Diabetes and Vascular Disease Research · doi:10.1177/1479164113514239 · Cited by 49
Muiesan, M. L., Ambrosioni, E., Costa, F. V., Leonetti, G., Pessina, A. C., Salvetti, M., Trimarco, B., Volpe, M., Pontremoli, R., Deferrari, G., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328359b6a9 · Cited by 44
de León, A. C., Coello, S. D., González, D. A., Díaz, B. B., Rodríguez, J. C. D. C., Hernández, A. G., Aguirre‐Jaime, A., & Pérez, M. D. C. R. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03420.x · Cited by 48
Treating prediabetes: why and how should we do it?
Braga, T. G., Kraemer‐Aguiar, L. G., Docherty, N. G., & le Roux, C. W. (2019) · Minerva Medica · doi:10.23736/s0026-4806.18.05897-4 · Cited by 45
Neves, J. S., Correa, S., Baptista, R. B., Vieira, M. B., Waikar, S. S., & Causland, F. R. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa017 · Cited by 45
Baber, U., Bander, J. A., Karajgikar, R., Yadav, K., Hadi, A., Theodoropolous, K., Gukathasan, N., Roy, S., Sayeneni, S., Scott, S. A., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0004 · Cited by 42
“These differences likely reflect the higher risk and selected nature of our PCI population compared to nationally representative cohorts (24).”
BackgroundResultBlood pressure response to acute and chronic exercise in chronic kidney disease
Headley, S., Germain, M., Wood, R. J., Joubert, J., Milch, C. M., Evans, E. E., Cornelius, A. E., Brewer, B. W., Taylor, B. A., & Pescatello, L. S. (2016) · Nephrology · doi:10.1111/nep.12730 · Cited by 40
Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm
Bar‐Tana, J. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09545-w · Cited by 44
“Most importantly, pre-diabetes is already associated with an established cardiovascular disease [18,19], nephropathy [20], neuropathy [21,22], retinopathy [23] and all-cause mortality [24].”
BackgroundZhou, Y., Zhang, Y., Zhang, R., Zhou, Y., Li, N., Wang, M., Tian, H., & Li, S. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001407 · Cited by 41
“Comorbidities of hypertension and chronic kidney disease were markedly less frequent among outpatients and inpatients with diabetes in our study compared with those in the trial population; this was in contrast with findings in previous population-based studies in various ethnicities.([26,33-36]) Of note, lower use of…”
ResultAl‐Rifai, R. H., Majeed, M., Qambar, M. A., Ibrahim, A., Alyammahi, K. M., & Aziz, F. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1187-1 · Cited by 44
Linagliptin: a novel dipeptidyl peptidase 4 inhibitor with a unique place in therapy
Barnett, A. H. (2011) · Advances in Therapy · doi:10.1007/s12325-011-0028-y · Cited by 44
Chronic Microvascular Complications in Prediabetic States—An Overview
Baranowska-Jurkun, A., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103289 · Cited by 43
“For some years, evidence for a correlation between an increased risk of chronic kidney disease (CKD) and diabetic kidney disease (DKD) in prediabetes has been recorded [35,46].”
BackgroundLee, Y., Armstrong, E. J., Kim, G., Oh, J., Kang, S., Lee, B., Ahn, C. W., Soo, B., Lee, H. C., Mantzoros, C. S., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.024 · Cited by 39
Mihardja, L. K., Delima, D., Massie, R. G. A., Karyana, M., Nugroho, P., & Yunir, E. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0338-6 · Cited by 44
“7% in undiagnosed diabetes mellitus (UDDM) [10] Mihardja l.”
BackgroundAssociation of HbA1c and cardiovascular and renal disease in an adult Mediterranean population
Hernández, D., Espejo-Gil, A., Bernal-López, M. R., Mancera‐Romero, J., Baca-Osorio, A., Tinahones, F. J., Armas-Padrón, A. M., Esteban, P. R., Torres, A., & Gómez-Huelgas, R. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-151 · Cited by 42
“Background Chronic kidney disease (CKD), evidenced by either albuminuria or decreased kidney function, is increasing worldwide, especially in individuals with metabolic abnormalities, including dysglycemic disorders [1,2].”
BackgroundKang, S. H., Jung, D. J., Choi, E. W., Cho, K. H., Park, J. W., & Do, J. Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145827 · Cited by 39
“enrolled non-DM patients using data from the USA; however, this group evaluated the association between CKD and pre-diabetic status classified by fasting glucose level [28].”
MethodBattelino, T., Lalic, N. M., Hussain, S., Ceriello, A., Majanović, S. K., Davies, S., Topsever, P., Heverly, J., Ulivi, F., Brady, K., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112111 · Cited by 36
Ahluwalia, T. S., Schulz, C., Waage, J., Skaaby, T., Sandholm, N., Zuydam, N. V., Charmet, R., Bork‐Jensen, J., Almgren, P., Thuesen, B. H., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4783-z · Cited by 35
Association Between Shiftwork and Glomerular Filtration Rate in Police Officers
Charles, L. E., Gu, J. K., Fekedulegn, D. B., Andrew, M. E., Violanti, J. M., & Burchfiel, C. M. (2013) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3182a299c9 · Cited by 36
“41,42 In addition to the association between sleep and diabetes, studies also show a positive association between inadequate sleep duration and obesity.”
Zhou, Y., Echouffo-Tcheugui, J. B., Gu, J.-J., Ruan, X., Zhao, G.-M., Xu, W., Yang, L.-M., Zhang, H., Qiu, H., Narayan, K. M. V., et al. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-253 · Cited by 35
“The prevalence of CKD obtained with the MDRD Study equation was relatively low compared to that obtained in other populations [15,39].”
BackgroundResultInfluentialMeijnikman, A. S., Block, C. E. M. D., Verrijken, A., Mertens, I. L., Corthouts, B., & Gaal, L. F. V. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.004 · Cited by 36
Møller, G., Rikardt Andersen, J., Ritz, C., P. Silvestre, M., Navas-Carretero, S., Jalo, E., Christensen, P., Simpson, E., Taylor, M., Martinez, J., et al. (2018) · Nutrients · doi:10.3390/nu10010054 · Cited by 31
“According to the NHANES survey conducted in 1999–2006 [40] the incidence rate of chronic kidney disease is >40% among adults with a diagnosis of diabetes and 17.”
MethodAmri, T. A., Bahijri, S., Al-Raddadi, R. M., Ajabnoor, G., Al-Ahmadi, J., Jambi, H., Borai, A., & Tuomilehto, J. O. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s233717 · Cited by 39
Metadata
- Authors
- Plantinga, L. C., Crews, D. C., Coresh, J., Miller, E. R., Saran, R., Yee, J., Hedgeman, E., Pavkov, M., Eberhardt, M. S., Williams, D. E., & Powe, N. R.
- Affiliations
- San Francisco General Hospital (US)
- Johns Hopkins University (US)
- University of Michigan (US)
- Henry Ford Health (US)
- Centers for Disease Control and Prevention (US)
- University of California, San Francisco (US)
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2010-04
- Volume
- 5
- Issue
- 4
- Pages
- 673-682
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2849697
- OpenAlex
- W2128714303
- Cited by
- 408
- References
- 28
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 24 · 2023: 25 · 2022: 18 · 2021: 30 · 2020: 28 · 2019: 29 · 2018: 32 · 2017: 26 · 2016: 34 · 2015: 31 · 2014: 27 · 2013: 28 · 2012: 15
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K24 DK02643, K24DK002643)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- chronic kidney disease, undiagnosed diabetes, prediabetes, diabetes prevalence, albumin-creatinine ratio, estimated glomerular filtration rate, NHANES, diabetes screening
- MeSH terms
- Adult, Albuminuria, Blood Glucose, Chronic Disease, Creatinine, Diabetes Mellitus, Fasting, Female, Glomerular Filtration Rate, Health Surveys, Humans, Kidney Diseases, Male, Mass Screening, Middle Aged, Prediabetic State, Predictive Value of Tests, Surveys and Questionnaires, United States, Biomarkers, Comorbidity, Prevalence, Chi-Square Distribution, Logistic Models, Early Diagnosis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.